Expert Opinion on Emerging Drugs

译名:新兴药物专家观点

EXPERT OPINION ON EMERGING DRUGS

SCIEJCR Q2

3-5

2026

影响因子区间

平台估算

投稿周期

5%

2025

中国作者发文占比

2650 USD

费用说明

收费

期刊简介:Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.

【译文】《新兴药物专家意见》(ISSN 1472-8214 [印刷版],1744-7623 [电子版])是一本MEDLINE索引、同行评审的国际期刊,发表关于所有治疗领域新兴上市II期和III期药物/药物类别的结构化综述,提供专家对这些药物对当前特定疾病管理潜在影响的意见。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1472-8214
eISSN
1744-7623
出版频率
季刊
创刊年份
2001
投稿网址
https://www.tandfonline.com/loi/iemd20
最近更新
2026-04-02 18:16:40
Expert Opinion on Emerging Drugs

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无